The most commonly reported side effect of statins is muscle pain or weakness, but the actual picture is more nuanced than most people realize. In large clinical trials comparing statins to placebo pills, 27.1% of people on statins reported muscle symptoms, while 26.6% of people taking a placebo reported the exact same thing. That razor-thin difference points to something important: many of the side effects people attribute to statins aren’t caused by the drug itself. Still, statins do carry real risks worth understanding, from a modest increase in diabetes to rare but serious muscle damage.
Muscle Pain: The Most Common Complaint
Muscle aches and weakness are far and away the most talked-about statin side effect. People describe soreness, heaviness, cramping, or general fatigue in their muscles, often in the legs and arms. These symptoms are real and can genuinely affect quality of life. But the question of how often statins actually cause them, versus how often people expect them and then notice them, has been a major area of research.
A landmark crossover trial called SAMSON gave the same patients statin tablets, placebo tablets, and no tablets at all in random order. The results were striking: symptom scores during statin months averaged 16.3, during placebo months averaged 15.4, and during months with no pill at all averaged 8.0. Statin and placebo months were statistically indistinguishable from each other. The researchers calculated that about 90% of the symptoms people experienced while taking statins were also triggered by taking a placebo. This is the nocebo effect: expecting side effects from a medication makes you more likely to notice and attribute everyday aches to the drug.
None of this means your muscle pain isn’t real. It means the cause may not be the statin. If you’re experiencing muscle symptoms, it’s worth considering other explanations, including recent exercise, other medications, or conditions like thyroid problems, before stopping a drug that’s protecting your heart.
Who Is More Likely to Experience Side Effects
Certain people face a higher risk of genuine statin-related muscle problems. Adults over 65 are roughly twice as likely to develop muscle issues compared to younger patients. Women appear to be more vulnerable than men, and people of Chinese or East Asian ancestry may also face elevated risk. Underlying conditions like hypothyroidism, kidney impairment, and preexisting muscle disease all increase susceptibility.
Genetics play a role too. A specific gene variant called SLCO1B1 dramatically raises myopathy risk. People carrying two copies of this variant have roughly 17 times the odds of developing statin-related muscle problems compared to those without it. Genetic testing for this variant is available and sometimes used when someone has had muscle issues on multiple statins.
Drug interactions are another major factor. Several statins are processed by the same liver enzyme, and other medications that compete for that enzyme can effectively raise statin levels in the blood. Common culprits include certain calcium channel blockers (used for blood pressure), antifungal medications, some antibiotics, HIV medications, and the cholesterol drug gemfibrozil. If you take multiple medications, your prescriber should be checking for these interactions.
Diabetes Risk
Statins slightly raise blood sugar levels and increase the chance of being diagnosed with type 2 diabetes. The size of this effect depends on the dose. Low-to-moderate intensity statin therapy raises new diabetes diagnoses by about 10%. High-intensity therapy raises it by about 36%. To put that in perspective, if your baseline risk of developing diabetes over five years was, say, 5%, a high-intensity statin might push that to roughly 6.8%.
This risk is highest in people who are already on the edge of diabetes: those with elevated fasting glucose, higher BMI, or other metabolic risk factors. For most people, the cardiovascular benefit of statins substantially outweighs the diabetes risk. But if you’re already prediabetic, it’s something worth monitoring with periodic blood sugar checks.
Liver Effects
Mild elevations in liver enzymes are common with statin use and, on their own, are not considered dangerous. Routine liver monitoring used to be standard practice, but guidelines have pulled back from that because clinically significant liver injury from statins is extremely rare. The threshold doctors watch for is a sustained rise in liver enzymes to more than three times the normal level combined with elevated bilirubin (a marker of actual liver damage). Reaching that threshold is uncommon enough that regular screening in people without symptoms is no longer recommended.
Memory and Cognitive Effects
In 2012, the FDA added a label warning to all statins about possible cognitive effects, including memory loss, confusion, and fuzzy thinking. These reports are generally described as reversible, resolving after stopping the medication. However, the evidence is inconsistent, and the risk appears to vary by the type of statin.
Statins that dissolve more easily in fat (called lipophilic statins) cross into the brain more readily. Two of the most widely prescribed statins, atorvastatin and simvastatin, fall into this category and show a noticeably higher signal for cognitive side effects in adverse event databases. Water-soluble (hydrophilic) statins like rosuvastatin and pravastatin do not show the same pattern. If you’re concerned about cognitive effects, this distinction is worth discussing with your prescriber, because switching statin types may resolve the issue without giving up the cardiovascular benefit.
Rhabdomyolysis: Rare but Serious
Rhabdomyolysis is the most severe muscle-related side effect of statins. It involves rapid breakdown of muscle tissue, releasing proteins into the bloodstream that can damage the kidneys. It’s also genuinely rare. For the most commonly used statin doses, the incidence is roughly 2 per 100,000 person-years. At higher doses, that climbs to around 11.5 per 100,000 person-years. For context, that means if 100,000 people took a high-dose statin for a year, about 12 of them would develop rhabdomyolysis.
Warning signs include severe muscle pain that comes on suddenly, dark or cola-colored urine, and unusual weakness. These symptoms warrant immediate medical attention. The risk is highest when statins are combined with interacting drugs, in older patients, and in people with kidney problems.
What to Do If You’re Having Side Effects
If you develop muscle symptoms on a statin, the first step is figuring out whether the statin is actually the cause. Your doctor should look at other possible explanations: recent changes in physical activity, drug interactions that might be raising your statin levels, and conditions like hypothyroidism that mimic statin side effects. A blood test measuring creatine kinase (CK) can help determine whether actual muscle damage is occurring or whether the symptoms are muscular discomfort without tissue injury.
If the statin does appear to be responsible, several options exist. Switching to a different statin often works, since people who have trouble with one may tolerate another just fine. Another approach is taking a long-acting statin (like rosuvastatin) less frequently, such as every other day, which lowers the effective dose while still providing meaningful cholesterol reduction. Current guidelines emphasize that even a reduced dose of a statin is better than none at all for people at significant cardiovascular risk.
For people who truly cannot tolerate any statin at any dose, non-statin alternatives are available. Bempedoic acid lowers cholesterol through a different pathway and has shown cardiovascular benefits in a large trial of patients who couldn’t take statins. Ezetimibe, which blocks cholesterol absorption in the gut, is another add-on option. For higher-risk patients, injectable PCSK9 inhibitors provide potent cholesterol lowering with a side effect profile distinct from statins. A newer option, inclisiran, requires only two injections per year for those who prefer less frequent dosing.
The goal isn’t to choose between side effects and heart protection. It’s to find the approach that delivers both.